Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022–2024)
Pablo Ryan, Juan González(University of California, San Francisco), Eva Orviz(Hospital Clínico San Carlos), María Jesús Vivancos(Hospital Universitario Ramón y Cajal), Ignacio de los Santos, Luis Ramos‐Ruperto(Hospital Universitario La Paz), Juan Berenguer(Instituto de Salud Carlos III), Inmaculada Jarrín(Instituto de Salud Carlos III), Beatriz López Centeno(Madrid Health Service), Luz Martín‐Carbonero, Mar Vera(Hospital Clínico San Carlos), Rafael Torres(Universidade Federal de Minas Gerais), Adriana Pinto(Centro de Investigación Biomédica en Red), José Sanz, Pilar Ruíz-Seco(Hospital Universitario Infanta Sofía), José M. Bellón(Hospital General Universitario Gregorio Marañón), Marta de Miguel(Fundación Seimc-Gesida), Beatriz Álvarez(Hospital Universitario Fundación Jiménez Díaz), Leire Pérez‐Latorre, Beatriz Brazal(Fundación Seimc-Gesida), Salvador Resino(Instituto de Salud Carlos III)
Cited by 1
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Autologous hematopoietic stem cell transplantation in multiple sclerosis
|Neurology|2015|247